| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| R&D Expense | $22.9M | -1.7% |
| SG&A Expense | $10.9M | -13.6% |
| Operating Income | -$33.8M | -4.4% |
| Interest Expense | $2.9M | +29.7% |
| Income Tax | $0 | — |
| Net Income | -$35.8M | -58.0% |
| EPS (Basic) | -$16.37 | -2876.4% |
| EPS (Diluted) | -$16.37 | -2876.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14.9M | +70.8% |
| Short-term Investments | $3.5M | -80.1% |
| Current Assets | $19.8M | -29.2% |
| Total Assets | $20.5M | -29.3% |
| Current Liabilities | $25.8M | +2.9% |
| Long-term Debt | $20.0M | +0.0% |
| Total Liabilities | $26.3M | +4.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$29.6M | -14.1% |
| Investing Cash Flow | $14.5M | +181.1% |
| Financing Cash Flow | $21.2M | +667.9% |
| Stockholders' Equity |
| -$5.8M |
| -248.7% |